Carlini EA, Hamaoui A, Bieniek D, Korte F (1970) Effects of (−)Δ9-_trans_-tetrahydrocannabinol and a synthetic derivative on maze performance of rats. Pharmacology 4: 359–368 PubMed Google Scholar
Collins DR, Pertwee RG, Davies SN (1995) Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid-meidated blockade of long-term potentiation in the rat hippocampal slice. Br J Pharmacol 115: 869–870 PubMed Google Scholar
Compton DR, Gold LH, Ward SJ, Balster RL, Martin BR (1992a) Aminoalkylindole analogs: Cannabimimetic activity of a class of compounds structurally distinct from Δ9-tetrahydrocannabinol. J Pharmacol Exp Ther 263: 1118–1126 PubMed Google Scholar
Compton DR, Johnson MR, Melvin LS, Martin BR (1992) Pharmacological profile of a series of bicyclic cannabinoid analogs — classification as cannabimimetic agents. J Pharmacol Exp Ther 260: 201–209 PubMed Google Scholar
Compton DR, Rice KC, Costa BRd, Razdan RK, Melvin LS, Johnson MR, Martin BR (1993) Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 265: 218–226 PubMed Google Scholar
Compton DR, Aceto MD, Lowe J, Martin BR (1996) In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of Δ9-tetrahydrocannabinol-induced responses and apparent agonist activity. J Pharmacol Exper Ther 277: 586–594 Google Scholar
Crawley JN, Corwin RL, Robinson JK, Felder CC, Devane WA, Axelrod J (1993) Anandamide, and endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol Biochem Behav 46: 967–972 ArticlePubMed Google Scholar
Dennes RP, Barnes JC (1993) Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and noncholinomimetic drugs using a novel task in the 12-arm radial maze. Psychopharmacology 111: 435–441 PubMed Google Scholar
Deutsch DG, Chin SA (1993) Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol 46: 791–796 ArticlePubMed Google Scholar
Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946–1949 PubMed Google Scholar
Evans EB, Wenger GR (1992) Effects of drugs of abuse on acquistion of behavioral chains in squirrel monkeys. Psychopharmacology 107: 55–60 Google Scholar
Ferraro DP, Grilly DM (1973) Lack of tolerance to Δ9-tetrahydrocannabinol in chimpanzees. Science 179: 490–492 PubMed Google Scholar
Ferri S, Costa G, Murari G, Panico AM, Rapisarda E, Speroni E, Arrigo RR (1981) Investigations on behavioral effects of an extract of Cannabis sativa L. in the rat. Psychopharmacology 75: 144–147 ArticlePubMed Google Scholar
Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantative in vitro autoradiographic study. J Neurosci 11: 563–583 PubMed Google Scholar
Heyser CJ, Hampson RE, Deadwyler SA (1993) Effects of delta9-tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells. J Pharmacol Exp Ther 264: 294–307 PubMed Google Scholar
Levin ED, Rose JE (1991) Interactive effects of D1 and D2 agonists with scopolamine on radial-arm maze performance. Pharmacol Biochem Behav 38: 243–246 ArticlePubMed Google Scholar
Lichtman AH, Dimen KR, Martin BR (1995) Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology 119: 282–290 ArticlePubMed Google Scholar
Little PJ, Compton DR, Johnson MR, Melvin LS, Martin BR (1988) Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J Pharmacol Exp Ther 247: 1046–1051 PubMed Google Scholar
Martin BR (1986) Cellular effects of cannabinoids. Pharmacol Rev 38: 45–74 PubMed Google Scholar
Matsuoka N, Maeda N, Ohkubo Y, Yamaguchi I (1991) Differential effects of physostigmine and pilocarpine on the spatial memory deficits produced by two septo-hippocampal deafferentations in rats. Brain Res 559: 233–240 ArticlePubMed Google Scholar
McConnell WR, Dewey WL, Harris LS, Borzelleca JF (1978) A study of the effect of delta9-tetrahydrocannabinol (delta9-THC) on mammalian salivary flow. J Pharmacol Exp Ther 206: 567–573 PubMed Google Scholar
McGurk SR, Levin ED, Butcher LL (1991) Impairment of radialarm maze performance in rats following lesions involving the cholinergic medial pathway: reversal by arecoline and differential effects of muscarinic and nicotinic antagonists. Neuroscience 44: 137–147 Google Scholar
McGurk SR, Levin ED, Butcher LL (1992) Dopaminergic drugs reverse the impairment of radial-arm maze performance caused by lesions involving the cholinergic medial pathway. Neuroscience 50: 129–135 ArticlePubMed Google Scholar
Murray CL, Fibiger BC (1985) Learning and memory deficits after lesions of the nucleus basalis magnocellularis: reversal by physostigmine. Neuroscience 14: 1025–1032 ArticlePubMed Google Scholar
Nakamura EM, da Silva EA, Concilio GV, Wilkinson DA, Masur J (1991) Reversible effects of acute and long-term administration of Δ9-tetrahydrocannabinol (THC) on memory in the rat. Drug Alcohol Depend 28: 167–175 ArticlePubMed Google Scholar
Olton DS (1987) The radial arm maze as a tool in behavioral pharmacology. Physiol Behav 40: 793–797 ArticlePubMed Google Scholar
Paton WDM, Aboo Zar M (1968) The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips. J Physiol 194: 13–33 PubMed Google Scholar
Pertwee RG, Ross TM (1991) Drugs which stimulate or facilitate central cholinergic transmission interact synergistically with Δ9-tetrahydrocannabinol to produce marked catalepsy in mice. Neuropharmacology 30: 67–71 ArticlePubMed Google Scholar
Prescott WR, Gold LH, Martin BR (1992) Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by Δ9-THC in the rat. Psychopharmacology 107: 117–124 ArticlePubMed Google Scholar
Revuelta AV, Cheney DL, Costa E, Lander N, Mechoulam R (1980) Reduction of hippocampal acetylcholine turnover in rats treated with (-)-delta 8-tetrahydrocannabinol and its 1′,2′-dimethyl-heptyl homolog. Brain Res 195: 445–452 ArticlePubMed Google Scholar
Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, Ferrara P, Soubrié P, Brelière JC, Le Fur G (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350: 240–244 ArticlePubMed Google Scholar
Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Alonso R, Congy C, Soubrié P, Brelière JC, Le Fur G (1995) Biochemical and pharmacological characterization of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci 56: 1941–1947 ArticlePubMed Google Scholar
Tallarida RJ, Murray RB (1987) Manual of pharmacologic calculations with computer programs, 2nd edn. Springer, New York Google Scholar
Tilson HA, McLamb RL, Shaw S, Rogers BC, Pediatitakis P, Cook L (1988) Radial-arm maze deficits produced by colchicine administered into the area of the nucleus basalis are ameliorated by cholinergic agents. Brain Res 438: 83–94 Google Scholar
Tripathi HL, Vocci FJ, Brase DA, Dewey WL (1987) Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain. Alcohol Drug Res 7: 525–532 PubMed Google Scholar
Westlake TM, Howlett AC, Bonner TI, Matsuda LA, Herkenham M (1994) Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neuroscience 63: 637–652 ArticlePubMed Google Scholar
Wiley JL, Lowe J, Balster RL, Martin BR (1995a) Antagonism of the discriminative stimulus effects of Δ9-THC in rats and rhesus monkeys. J Pharmacol Exp Ther 275: 1–6 PubMed Google Scholar
Wiley JL, Barrett RL, Lowe J, Balster RL, Martin BR (1995b) Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats. Neuropharmacology 34: 669–676 ArticlePubMed Google Scholar